McKesson Corporation (MCK) is a publicly traded Healthcare sector company. As of August 24, 2026, MCK trades at $865.10 with a market cap of $100.14B and a P/E ratio of 22.95. MCK moved +0.72% today. Year to date, MCK is +4.71%; over the trailing twelve months it is +21.66%. Its 52-week range spans $565.75 to $999.00. Analyst consensus is strong buy with an average price target of $987.75. Rallies surfaces MCK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MCK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $865.10 |
| Market Cap | $100.14B |
| P/E Ratio | 22.95 |
| EPS | $37.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $999.00 |
| 52-Week Low | $565.75 |
| Volume | 18 |
| Avg Volume | 0 |
| Revenue (TTM) | $410.98B |
| Net Income | $5.30B |
| Gross Margin | 3.64% |
13 analysts cover MCK: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $987.75.